Japan’s Pharmaceutical Affairs Law Reforms Threaten In-Country Caretakers
This article was originally published in The Gray Sheet
Executive Summary
Changes in Japan's new medical device-governing pharmaceutical law will effectively dismantle the nation's in-country caretaker (ICC) system, according to Pacific Bridge, Inc. President Ames Gross
You may also be interested in...
Japan Reforms Failed To Sate U.S. Firms In 2002; EU Reuse Drive Ebbs, Wanes
AdvaMed will capitalize on new Exec. VP-Global Strategy & Analysis Marjory Searing's rapport with Japan Ministry of Health, Labor & Welfare officials to renew its assault on foreign reference pricing in 2003
Japan Reforms Failed To Sate U.S. Firms In 2002; EU Reuse Drive Ebbs, Wanes
AdvaMed will capitalize on new Exec. VP-Global Strategy & Analysis Marjory Searing's rapport with Japan Ministry of Health, Labor & Welfare officials to renew its assault on foreign reference pricing in 2003
Japan Device Reforms To Pharmaceutical Law Include Third-Party Review
Establishment of a third-party review system and adoption of globally harmonized standards are among medical device regulatory changes under consideration by Japan's Ministry of Health, Labor & Welfare